Baradari V et al. |
Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells. |
2006 |
Endocr. Relat. Cancer |
pmid:17158768
|
Kogai T et al. |
Enhancement of sodium/iodide symporter expression in thyroid and breast cancer. |
2006 |
Endocr. Relat. Cancer |
pmid:16954431
|
López-Solache I et al. |
Regulation of uncoupling protein-2 mRNA in L6 myotubules: II: Thyroid hormone amplifies stimulation of uncoupling protein-2 gene by thiazolidinediones and other peroxisome proliferator-activated receptor ligands in L6 myotubules: evidence for a priming effect. |
2002 |
Endocrine |
pmid:12588052
|
Ruh MF et al. |
The effects of histone acetylation on estrogen responsiveness in MCF-7 cells. |
1999 |
Endocrine |
pmid:10709763
|
Kim SH et al. |
The heat shock protein 90 inhibitor SNX5422 has a synergistic activity with histone deacetylase inhibitors in induction of death of anaplastic thyroid carcinoma cells. |
2016 |
Endocrine |
pmid:26219406
|
Uchida H et al. |
Histone deacetylase inhibitors stimulate cell migration in human endometrial adenocarcinoma cells through up-regulation of glycodelin. |
2007 |
Endocrinology |
pmid:17068141
|
Cho JH et al. |
DNA methylation regulates placental lactogen I gene expression. |
2001 |
Endocrinology |
pmid:11459782
|
Walker GE et al. |
Butyrate, a histone deacetylase inhibitor, activates the human IGF binding protein-3 promoter in breast cancer cells: molecular mechanism involves an Sp1/Sp3 multiprotein complex. |
2001 |
Endocrinology |
pmid:11517158
|
Yacqub-Usman K et al. |
Preincubation of pituitary tumor cells with the epidrugs zebularine and trichostatin A are permissive for retinoic acid-augmented expression of the BMP-4 and D2R genes. |
2013 |
Endocrinology |
pmid:23539512
|
Ho AK et al. |
Acetylation of histone H3 and adrenergic-regulated gene transcription in rat pinealocytes. |
2007 |
Endocrinology |
pmid:17628002
|
Li Q et al. |
Bisphenol A and Phthalates Modulate Peritoneal Macrophage Function in Female Mice Involving SYMD2-H3K36 Dimethylation. |
2018 |
Endocrinology |
pmid:29718165
|
Uchida H et al. |
Histone deacetylase inhibitors induce differentiation of human endometrial adenocarcinoma cells through up-regulation of glycodelin. |
2005 |
Endocrinology |
pmid:16123169
|
Zhang J et al. |
Inhibition of glyceroneogenesis by histone deacetylase 3 contributes to lipodystrophy in mice with adipose tissue inflammation. |
2011 |
Endocrinology |
pmid:21406501
|
Mao C and Shapiro DJ |
A histone deacetylase inhibitor potentiates estrogen receptor activation of a stably integrated vitellogenin promoter in HepG2 cells. |
2000 |
Endocrinology |
pmid:10875235
|
Hu JF et al. |
Allele-specific histone acetylation accompanies genomic imprinting of the insulin-like growth factor II receptor gene. |
2000 |
Endocrinology |
pmid:11108251
|
Yang Y et al. |
The histone code regulating expression of the imprinted mouse Igf2r gene. |
2003 |
Endocrinology |
pmid:12975326
|
Bhargavan B et al. |
Epigenetic repression of LEDGF during UVB exposure by recruitment of SUV39H1 and HDAC1 to the Sp1-responsive elements within LEDGF promoter CpG island. |
2013 |
Epigenetics |
pmid:23386123
|
Ooi JY et al. |
HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes. |
2015 |
Epigenetics |
pmid:25941940
|
Devaney JM et al. |
Genome-wide differentially methylated genes in prostate cancer tissues from African-American and Caucasian men. |
2015 |
Epigenetics |
pmid:25864488
|
Huisman C et al. |
Prolonged re-expression of the hypermethylated gene EPB41L3 using artificial transcription factors and epigenetic drugs. |
2015 |
Epigenetics |
pmid:25830725
|
Fan H et al. |
Sulforaphane causes a major epigenetic repression of myostatin in porcine satellite cells. |
2012 |
Epigenetics |
pmid:23092945
|
Chen J et al. |
Interplay of bromodomain and histone acetylation in the regulation of p300-dependent genes. |
2010 |
Epigenetics |
pmid:20505343
|
Mateen S et al. |
Epigenetic modifications and p21-cyclin B1 nexus in anticancer effect of histone deacetylase inhibitors in combination with silibinin on non-small cell lung cancer cells. |
2012 |
Epigenetics |
pmid:22965008
|
Good KV et al. |
Trichostatin A decreases the levels of MeCP2 expression and phosphorylation and increases its chromatin binding affinity. |
2017 |
Epigenetics |
pmid:29099289
|
Mostovich LA et al. |
The TCF4/β-catenin pathway and chromatin structure cooperate to regulate D-glucuronyl C5-epimerase expression in breast cancer. |
2012 |
Epigenetics |
pmid:22805760
|
Zhang YW et al. |
Integrated analysis of DNA methylation and mRNA expression profiling reveals candidate genes associated with cisplatin resistance in non-small cell lung cancer. |
2014 |
Epigenetics |
pmid:24699858
|
Deneberg S et al. |
microRNA-34b/c on chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemia. |
2014 |
Epigenetics |
pmid:24686393
|
Soriano FX et al. |
Role of histone acetylation in the activity-dependent regulation of sulfiredoxin and sestrin 2. |
2009 |
Epigenetics |
pmid:19430206
|
da Costa Prando E et al. |
Evidence of epigenetic regulation of the tumor suppressor gene cluster flanking RASSF1 in breast cancer cell lines. |
2011 |
Epigenetics |
pmid:22139571
|
Tost J et al. |
Methylation of specific CpG sites in the P2 promoter of parathyroid hormone-related protein determines the invasive potential of breast cancer cell lines. |
2011 |
Epigenetics |
pmid:21775817
|
Costa VL et al. |
TCF21 and PCDH17 methylation: An innovative panel of biomarkers for a simultaneous detection of urological cancers. |
2011 |
Epigenetics |
pmid:21847011
|
Yang PM et al. |
CD1d induction in solid tumor cells by histone deacetylase inhibitors through inhibition of HDAC1/2 and activation of Sp1. |
2012 |
Epigenetics |
pmid:22419072
|
Mayor R et al. |
Dynamics of bivalent chromatin domains upon drug induced reactivation and resilencing in cancer cells. |
2011 |
Epigenetics |
pmid:21852760
|
Singh T et al. |
Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo. |
2013 |
Epigenetics |
pmid:23221619
|
Li Q and Chen H |
Silencing of Wnt5a during colon cancer metastasis involves histone modifications. |
2012 |
Epigenetics |
pmid:22522911
|
Meier BC and Wagner BK |
Inhibition of HDAC3 as a strategy for developing novel diabetes therapeutics. |
2014 |
Epigenomics |
pmid:24811789
|
Poplineau M et al. |
Raman microspectroscopy detects epigenetic modifications in living Jurkat leukemic cells. |
2011 |
Epigenomics |
pmid:22126296
|
Barr MP et al. |
VEGF-mediated cell survival in non-small-cell lung cancer: implications for epigenetic targeting of VEGF receptors as a therapeutic approach. |
2015 |
Epigenomics |
pmid:26479311
|
Hoffmann K et al. |
Increase in antiepileptic efficacy during prolonged treatment with valproic acid: role of inhibition of histone deacetylases? |
2008 |
Epilepsy Res. |
pmid:18538545
|
Duharcourt S and Yao MC |
Role of histone deacetylation in developmentally programmed DNA rearrangements in Tetrahymena thermophila. |
2002 |
Eukaryotic Cell |
pmid:12455963
|
Juranek SA et al. |
snRNA and heterochromatin formation are involved in DNA excision during macronuclear development in stichotrichous ciliates. |
2005 |
Eukaryotic Cell |
pmid:16278460
|
Tong K et al. |
Schizosaccharomyces pombe Hat1 (Kat1) is associated with Mis16 and is required for telomeric silencing. |
2012 |
Eukaryotic Cell |
pmid:22771823
|
GarcÃa I et al. |
Chromatin rearrangements in the prnD-prnB bidirectional promoter: dependence on transcription factors. |
2004 |
Eukaryotic Cell |
pmid:14871945
|
Smetana K et al. |
To the nucleolar density and size in apoptotic human leukemic myeloblasts produced in vitro by Trichostatin A. |
2008 Jul-Sep |
Eur J Histochem |
pmid:18840553
|
Chen Y et al. |
3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment. |
2009 |
Eur J Med Chem |
pmid:19136179
|
Marrazzo A et al. |
Antiproliferative activity of phenylbutyrate ester of haloperidol metabolite II [(±)-MRJF4] in prostate cancer cells. |
2011 |
Eur J Med Chem |
pmid:21055848
|
Hou J et al. |
Structure-based optimization of click-based histone deacetylase inhibitors. |
2011 |
Eur J Med Chem |
pmid:21621883
|
Huang D et al. |
A novel series of l-2-benzyloxycarbonylamino-8-(2-pyridyl)-disulfidyloctanoic acid derivatives as histone deacetylase inhibitors: design, synthesis and molecular modeling study. |
2012 |
Eur J Med Chem |
pmid:22465091
|
Ragno R et al. |
Class II-selective histone deacetylase inhibitors. Part 2: alignment-independent GRIND 3-D QSAR, homology and docking studies. |
2008 |
Eur J Med Chem |
pmid:17698257
|
Bertrand P |
Inside HDAC with HDAC inhibitors. |
2010 |
Eur J Med Chem |
pmid:20223566
|